Literature DB >> 33386568

A retrospective study of the risk factors and the prognosis in patients with papillary thyroid carcinoma depending on the number of lymph node metastasis.

Zhong Ying Rui1, Yang Liu2, Wei Zheng3, Xuan Wang1, Zhao Wei Meng1, Jian Tan1, Ning Li1, Qiang Jia1.   

Abstract

To retrospectively analyze the risk factors and the prognosis according to the number of lymph node metastases (LNMs) in different neck compartments in papillary thyroid carcinoma (PTC) patients. In total, 962 patients with PTC were enrolled in this study. According to the methods of the 2015 American Thyroid Association, the treatment response of the patients was divided into a good prognosis and a poor prognosis. First, their clinical characteristics were summarized. Then, according to whether they had LNMs and the number of LNMs in different neck compartments, their risk factors and their prognosis were analyzed. Male sex, younger (< 45 years), extrathyroid extension (ETE), T1 staging and higher stimulated thyroglobulin (sTg) levels were the risk factors for LNM. The cutoff for a poor prognosis of the number of LNMs was > 4. Male sex, younger age, higher sTg levels and ETE were correlated with LNM > 4. Furthermore, the cutoffs for a poor prognosis of central lymph node metastasis (CLNM), lateral lymph node metastasis (LLNM) and CLNM + LLNM were > 6, > 1 and > 5, respectively. Younger age and ETE were strongly correlated with CLNM > 6. Male sex, younger age, higher sTg levels and ETE were correlated with LLNM > 1. Younger age, ETE and higher sTg levels were correlated with CLNM + LLNM > 5. Further analysis revealed a positive correlation between CLNM and LLNM. We should pay more attention to LNMs in PTC patients who are male, are of a younger age, have ETE, T1 staging and have higher sTg levels. The neck regional LNMs should be correctly evaluated to guide the surgical options for the neck LNMs in PTC. When the number of LNMs in different neck compartments has exceeded the cutoff value, they can be considered as predictors of the outcome of 131I treatment.

Entities:  

Keywords:  Cutoff value; Lymph node metastases; Neck compartments; Papillary thyroid carcinoma; Prognosis; Risk factors

Year:  2021        PMID: 33386568     DOI: 10.1007/s10238-020-00675-8

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  42 in total

1.  The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer.

Authors:  Yale D Podnos; David Smith; Lawrence D Wagman; Joshua D I Ellenhorn
Journal:  Am Surg       Date:  2005-09       Impact factor: 0.688

Review 2.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

3.  Pattern of lymph node metastases in papillary thyroid carcinoma.

Authors:  O Gimm; F W Rath; H Dralle
Journal:  Br J Surg       Date:  1998-02       Impact factor: 6.939

4.  Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection.

Authors:  Nobuyuki Wada; Quan-Yang Duh; Kiminori Sugino; Hiroyuki Iwasaki; Kaori Kameyama; Takashi Mimura; Koichi Ito; Hiroshi Takami; Yoshinori Takanashi
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

5.  Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes.

Authors:  Tracy S Wang; Sanford Dubner; Laura A Sznyter; Keith S Heller
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-01

Review 6.  Involvement of level IIb lymph node metastasis and dissection in thyroid cancer.

Authors:  Yusuf Vayisoglu; Cengiz Ozcan
Journal:  Gland Surg       Date:  2013-11

7.  Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer.

Authors:  G F Scheumann; O Gimm; G Wegener; H Hundeshagen; H Dralle
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

8.  Skip metastases in thyroid cancer leaping the central lymph node compartment.

Authors:  Andreas Machens; Hans-Jürgen Holzhausen; Henning Dralle
Journal:  Arch Surg       Date:  2004-01

9.  Clinical predictors of right upper paraesophageal lymph node metastasis from papillary thyroid carcinoma.

Authors:  Yong-Seok Kim; Woo-Chan Park
Journal:  World J Surg Oncol       Date:  2012-08-16       Impact factor: 2.754

10.  Clinical Analysis of Risk Factors for Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study of 3686 Patients.

Authors:  Jianlu Song; Ting Yan; Wangwang Qiu; Youben Fan; Zhili Yang
Journal:  Cancer Manag Res       Date:  2020-04-09       Impact factor: 3.989

View more
  6 in total

1.  Development and validation of a novel 14-gene signature for predicting lymph node metastasis in papillary thyroid carcinoma.

Authors:  Yuwei Ling; Luyao Jia; Kaifu Li; Lina Zhang; Yajun Wang; Hua Kang
Journal:  Gland Surg       Date:  2021-09

2.  The efficacy and safety of microwave ablation versus conventional open surgery for the treatment of papillary thyroid microcarcinoma: a systematic review and meta-analysis.

Authors:  Xiaoyu Wu; Zixuan Jiang; Jie Liu; Na Liu; Qiqi Hu; Yi Xiong; Liuyi Zhang
Journal:  Gland Surg       Date:  2022-06

3.  Microarray profiling identifies hsa_circ_0082003 as a novel tumor promoter for papillary thyroid carcinoma.

Authors:  J Ye; J-W Feng; W-X Wu; G-F Qi; F Wang; J Hu; L-Z Hong; S-Y Liu; Y Jiang
Journal:  J Endocrinol Invest       Date:  2022-09-17       Impact factor: 5.467

4.  A Nomogram Based on Clinicopathological and Ultrasound Imaging Characteristics for Predicting Cervical Lymph Node Metastasis in cN0 Unilateral Papillary Thyroid Microcarcinoma.

Authors:  Lina Zhang; Yuwei Ling; Ye Zhao; Kaifu Li; Jing Zhao; Hua Kang
Journal:  Front Surg       Date:  2021-12-03

5.  Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma.

Authors:  Jiang Zhu; Rui Huang; Ping Yu; Haoyu Ren; Xinliang Su
Journal:  Int J Endocrinol       Date:  2022-02-28       Impact factor: 3.257

6.  Analysis of the Clinical Value of Delphian Lymph Node Metastasis in Papillary Thyroid Carcinoma.

Authors:  Qiumei Zuo; Xin Chen; Jingyu Yang; Shuang Qiu; Yuan Zhao; Jianwei Sun
Journal:  J Oncol       Date:  2022-06-10       Impact factor: 4.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.